Dextran-based Drug Delivery Approaches for Lung Diseases: A Review

Soriano, J.B.; Kendrick, P.J.; Paulson, K.R.; Gupta, V.; Abrams, E.M.; Adedoyin, R.A.; Adhikari, T.B.; Advani, S.M.; Agrawal, A.; Ahmadian, E.; Alahdab, F.; Aljunid, S.M.; Altirkawi, K.A.; Alvis-Guzman, N.; Anber, N.H.; Andrei, C.L.; Anjomshoa, M.; Ansari, F.; Antó, J.M.; Arabloo, J.; Athari, S.M.; Athari, S.S.; Awoke, N.; Badawi, A.; Banoub, J.A.M.; Bennett, D.A.; Bensenor, I.M.; Berfield, K.S.S.; Bernstein, R.S.; Bhattacharyya, K.; Bijani, A.; Brauer, M.; Bukhman, G.; Butt, Z.A.; Cámera, L.A.; Car, J.; Carrero, J.J.; Carvalho, F.; Castañeda-Orjuela, C.A.; Choi, J-Y.J.; Christopher, D.J.; Cohen, A.J.; Dandona, L.; Dandona, R.; Dang, A.K.; Daryani, A.; de Courten, B.; Demeke, F.M.; Demoz, G.T.; De Neve, J-W.; Desai, R.; Dharmaratne, S.D.; Diaz, D.; Douiri, A.; Driscoll, T.R.; Duken, E.E.; Eftekhari, A.; Elkout, H.; Endries, A.Y.; Fadhil, I.; Faro, A.; Farzadfar, F.; Fernandes, E.; Filip, I.; Fischer, F.; Foroutan, M.; Garcia-Gordillo, M.A.; Gebre, A.K.; Gebremedhin, K.B.; Gebremeskel, G.G.; Gezae, K.E.; Ghoshal, A.G.; Gill, P.S.; Gillum, R.F.; Goudarzi, H.; Guo, Y.; Gupta, R.; Hailu, G.B.; Hasanzadeh, A.; Hassen, H.Y.; Hay, S.I.; Hoang, C.L.; Hole, M.K.; Horita, N.; Hosgood, H.D.; Hostiuc, M.; Househ, M.; Ilesanmi, O.S.; Ilic, M.D.; Irvani, S.S.N.; Islam, S.M.S.; Jakovljevic, M.; Jamal, A.A.; Jha, R.P.; Jonas, J.B.; Kabir, Z.; Kasaeian, A.; Kasahun, G.G.; Kassa, G.M.; Kefale, A.T.; Kengne, A.P.; Khader, Y.S.; Khafaie, M.A.; Khan, E.A.; Khan, J.; Khubchandani, J.; Kim, Y-E.; Kim, Y.J.; Kisa, S.; Kisa, A.; Knibbs, L.D.; Komaki, H.; Koul, P.A.; Koyanagi, A.; Kumar, G.A.; Lan, Q.; Lasrado, S.; Lauriola, P.; La Vecchia, C.; Le, T.T.; Leigh, J.; Levi, M.; Li, S.; Lopez, A.D.; Lotufo, P.A.; Madotto, F.; Mahotra, N.B.; Majdan, M.; Majeed, A.; Malekzadeh, R.; Mamun, A.A.; Manafi, N.; Manafi, F.; Mantovani, L.G.; Meharie, B.G.; Meles, H.G.; Meles, G.G.; Menezes, R.G.; Mestrovic, T.; Miller, T.R.; Mini, G.K.; Mirrakhimov, E.M.; Moazen, B.; Mohammad, K.A.; Mohammed, S.; Mohebi, F.; Mokdad, A.H.; Molokhia, M.; Monasta, L.; Moradi, M.; Moradi, G.; Morawska, L.; Mousavi, S.M.; Musa, K.I.; Mustafa, G.; Naderi, M.; Naghavi, M.; Naik, G.; Nair, S.; Nangia, V.; Nansseu, J.R.; Nazari, J.; Ndwandwe, D.E.; Negoi, R.I.; Nguyen, T.H.; Nguyen, C.T.; Nguyen, H.L.T.; Nixon, M.R.; Ofori-Asenso, R.; Ogbo, F.A.; Olagunju, A.T.; Olagunju, T.O.; Oren, E.; Ortiz, J.R.; Owolabi, M.O. P A, M.; Pakhale, S.; Pana, A.; Panda-Jonas, S.; Park, E-K.; Pham, H.Q.; Postma, M.J.; Pourjafar, H.; Poustchi, H.; Radfar, A.; Rafiei, A.; Rahim, F.; Rahman, M.H.U.; Rahman, M.A.; Rawaf, S.; Rawaf, D.L.; Rawal, L.; Reiner, R.C., Jr; Reitsma, M.B.; Roever, L.; Ronfani, L.; Roro, E.M.; Roshandel, G.; Rudd, K.E.; Sabde, Y.D.; Sabour, S.; Saddik, B.; Safari, S.; Saleem, K.; Samy, A.M.; Santric-Milicevic, M.M.; Sao Jose, B.P.; Sartorius, B.; Satpathy, M.; Savic, M.; Sawhney, M.; Sepanlou, S.G.; Shaikh, M.A.; Sheikh, A.; Shigematsu, M.; Shirkoohi, R.; Si, S.; Siabani, S.; Singh, V.; Singh, J.A.; Soljak, M.; Somayaji, R.; Soofi, M.; Soyiri, I.N.; Tefera, Y.M.; Temsah, M-H.; Tesfay, B.E.; Thakur, J.S.; Toma, A.T.; Tortajada-Girbés, M.; Tran, K.B.; Tran, B.X.; Tudor Car, L.; Ullah, I.; Vacante, M.; Valdez, P.R.; van Boven, J.F.M.; Vasankari, T.J.; Veisani, Y.; Violante, F.S.; Wagner, G.R.; Westerman, R.; Wolfe, C.D.A.; Wondafrash, D.Z.; Wondmieneh, A.B.; Yonemoto, N.; Yoon, S-J.; Zaidi, Z.; Zamani, M.; Zar, H.J.; Zhang, Y.; Vos, T. Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir. Med., 2020, 8(6), 585-596.
[http://dx.doi.org/10.1016/S2213-2600(20)30105-3] [PMID: 32526187]

Gould, G.S.; Hurst, J.R.; Trofor, A.; Alison, J.A.; Fox, G.; Kulkarni, M.M.; Wheelock, C.E.; Clarke, M.; Kumar, R. Recognising the importance of chronic lung disease: A consensus statement from the Global Alliance for Chronic Diseases (Lung Diseases group). Respir. Res., 2023, 24(1), 15.
[http://dx.doi.org/10.1186/s12931-022-02297-y] [PMID: 36639661]

Ho, T.; Cusack, R.P.; Chaudhary, N.; Satia, I.; Kurmi, O.P. Under- and over-diagnosis of COPD: A global perspective. Breathe, 2019, 15(1), 24-35.
[http://dx.doi.org/10.1183/20734735.0346-2018] [PMID: 30838057]

Zanjbeel, M; Asghar, N; Aslam, M; Khalid, S; Islam, F; Raza, A Quality of life of participants with chronic respiratory disease.,

Varshosaz, J. Dextran conjugates in drug delivery. Expert Opin. Drug Deliv., 2012, 9(5), 509-523.
[http://dx.doi.org/10.1517/17425247.2012.673580] [PMID: 22432550]

Shen, Y.; Wang, X.; Xie, A.; Huang, L.; Zhu, J.; Chen, L. Synthesis of dextran/Se nanocomposites for nanomedicine application. Mater. Chem. Phys., 2008, 109(2-3), 534-540.
[http://dx.doi.org/10.1016/j.matchemphys.2008.01.016]

Sharma, S.; Naman, S.; Dwivedi, J.; Baldi, A. Dextran for application in dds for lung diseases. In: Natural Polymeric Materials based Drug Delivery Systems in Lung Diseases; Springer, 2023; pp. 297-327.
[http://dx.doi.org/10.1007/978-981-19-7656-8_17]

Mohan, T.; Kleinschek, K.S. Kargl, R Polysaccharide peptide conjugates: Chemistry, properties and applications. Carbohydr. Polym., 2022, 280, 118875.
[http://dx.doi.org/10.1016/j.carbpol.2021.118875]

Ioan, C.E.; Aberle, T.; Burchard, W. Structure properties of dextran. 2. Dilute solution. Macromolecules, 2000, 33(15), 5730-5739.
[http://dx.doi.org/10.1021/ma000282n]

Shigel, K.I. Determination of structural peculiarities of dextran, pulluan and gamma irradiated pullulan by Fourier-transform IR spectroscopy. Carbohydr. Res., 2002, 337, 2649-2701.

Mehvar, R. Dextrans for targeted and sustained delivery of therapeutic and imaging agents. J. Control. Release, 2000, 69(1), 1-25.
[http://dx.doi.org/10.1016/S0168-3659(00)00302-3] [PMID: 11018543]

Bachelder, E.M.; Beaudette, T.T.; Broaders, K.E.; Dashe, J.; Fréchet, J.M.J. Acetal-derivatized dextran: An acid-responsive biodegradable material for therapeutic applications. J. Am. Chem. Soc., 2008, 130(32), 10494-10495.
[http://dx.doi.org/10.1021/ja803947s] [PMID: 18630909]

Gannimani, R.; Walvekar, P.; Naidu, V.R.; Aminabhavi, T.M.; Govender, T. Acetal containing polymers as pH-responsive nano-drug de-livery systems. J. Control. Release, 2020, 328, 736-761.
[http://dx.doi.org/10.1016/j.jconrel.2020.09.044] [PMID: 32980419]

Meenach, S.A.; Kim, Y.J.; Kauffman, K.J.; Kanthamneni, N.; Bachelder, E.M.; Ainslie, K.M. Synthesis, optimization, and characterization of camptothecin-loaded acetalated dextran porous microparticles for pulmonary delivery. Mol. Pharm., 2012, 9(2), 290-298.
[http://dx.doi.org/10.1021/mp2003785] [PMID: 22149217]

Shah, N.K.; Gupta, S.K.; Wang, Z.; Meenach, S.A. Enhancement of macrophage uptake via phosphatidylserine-coated acetalated dextran nanoparticles. J. Drug Deliv. Sci. Technol., 2019, 50, 57-65.
[http://dx.doi.org/10.1016/j.jddst.2019.01.013]

Wang, Z.; Gupta, S.K.; Meenach, S.A. Development and physicochemical characterization of acetalated dextran aerosol particle systems for deep lung delivery. Int. J. Pharm., 2017, 525(1), 264-274.
[http://dx.doi.org/10.1016/j.ijpharm.2017.04.052] [PMID: 28450166]

Dellacherie, E.; Bonneaux, F. A new approach to aldehydic dextrans. Polym. Bull., 1993, 31(2), 145-149.
[http://dx.doi.org/10.1007/BF00329959]

Draye, J.P.; Delaey, B.; Van de Voorde, A.; Van Den Bulcke, A.; De Reu, B.; Schacht, E. In vitro and in vivo biocompatibility of dextran dialdehyde cross-linked gelatin hydrogel films. Biomaterials, 1998, 19(18), 1677-1687.
[http://dx.doi.org/10.1016/S0142-9612(98)00049-0] [PMID: 9840003]

Fuentes, M.; Mateo, C.; Fernandez-Lafuente, R.; Guisán, J.M. Aldehyde-dextran-protein conjugates to immobilize amino-haptens: Avoiding cross-reactions in the immunodetection. Enzyme Microb. Technol., 2005, 36(4), 510-513.
[http://dx.doi.org/10.1016/j.enzmictec.2004.11.004]

Betancor, L.; Fuentes, M.; Dellamora-Ortiz, G.; López-Gallego, F.; Hidalgo, A.; Alonso-Morales, N.; Mateo, C.; Guisán, J.M.; Fernández-Lafuente, R. Dextran aldehyde coating of glucose oxidase immobilized on magnetic nanoparticles prevents its inactivation by gas bubbles. J. Mol. Catal., B Enzym., 2005, 32(3), 97-101.
[http://dx.doi.org/10.1016/j.molcatb.2004.11.003]

Weng, L.; Romanov, A.; Rooney, J.; Chen, W. Non-cytotoxic, in situ gelable hydrogels composed of N-carboxyethyl chitosan and oxidized dextran. Biomaterials, 2008, 29(29), 3905-3913.
[http://dx.doi.org/10.1016/j.biomaterials.2008.06.025] [PMID: 18639926]

Weng, L.; Chen, X.; Chen, W. Rheological characterization of in situ crosslinkable hydrogels formulated from oxidized dextran and N-carboxyethyl chitosan. Biomacromolecules, 2007, 8(4), 1109-1115.
[http://dx.doi.org/10.1021/bm0610065] [PMID: 17358076]

Yu, L.; Cai, L.; Hu, H.; Zhang, Y. Experiments and synthesis of bone-targeting epirubicin with the water-soluble macromolecular drug delivery systems of oxidized-dextran. J. Drug Target., 2014, 22(4), 343-351.
[http://dx.doi.org/10.3109/1061186X.2013.877467] [PMID: 24405056]

Huang, Q.; Zhang, L.; Sun, X.; Zeng, K.; Li, J.; Liu, Y.N. Coating of carboxymethyl dextran on liposomal curcumin to improve the anticancer activity. RSC Advances, 2014, 4(103), 59211-59217.
[http://dx.doi.org/10.1039/C4RA11181H]

Huynh, R.; Chaubet, F.; Jozefonvicz, J. Carboxymethylation of dextran in aqueous alcohol as the first step of the preparation of derivatized dextrans. Angew. Makromol. Chem., 1998, 254(1), 61-65.
[http://dx.doi.org/10.1002/(SICI)1522-9505(19980201)254:1<61::AID-APMC61>3.0.CO;2-0]

McLean, K.M.; Johnson, G.; Chatelier, R.C.; Beumer, G.J.; Steele, J.G.; Griesser, H.J. Method of immobilization of carboxymethyl-dextran affects resistance to tissue and cell colonization. Colloids Surf. B Biointerfaces, 2000, 18(3-4), 221-234.
[http://dx.doi.org/10.1016/S0927-7765(99)00149-6] [PMID: 10915945]

Burns, D.L.; Mascioli, E.A.; Bistrian, B.R. Parenteral iron dextran therapy: A review. Nutrition, 1995, 11(2), 163-168.
[PMID: 7647482]

Martin, L.E.; Bates, C.M.; Beresford, C.R.; Donaldson, J.D. McDONALD, F.F.; Dunlop, D.; Sheard, P.; London, E.; Twigg, G.D. The pharmacology of an iron-dextran intramuscular haematinic. Br. J. Pharmacol. Chemother., 1955, 10(3), 375-382.
[http://dx.doi.org/10.1111/j.1476-5381.1955.tb00887.x] [PMID: 13269718]

Dhaneshwar, S.; Kandpal, M.; Gairola, N.; Kadam, S.S. Dextran: A promising macromolecular drug carrier. Indian J. Pharm. Sci., 2006, 68(6), 705-714.
[http://dx.doi.org/10.4103/0250-474X.31000]

Soliman, S.M.A.; Colombeau, L.; Nouvel, C.; Babin, J.; Six, J.L. Amphiphilic photosensitive dextran-g-poly(o-nitrobenzyl acrylate) glycopolymers. Carbohydr. Polym., 2016, 136, 598-608.
[http://dx.doi.org/10.1016/j.carbpol.2015.09.061] [PMID: 26572392]

Son, S.; Rao, N.V.; Ko, H.; Shin, S.; Jeon, J.; Han, H.S.; Nguyen, V.Q.; Thambi, T.; Suh, Y.D.; Park, J.H. Carboxymethyl dextran-based hypoxia-responsive nanoparticles for doxorubicin delivery. Int. J. Biol. Macromol., 2018, 110, 399-405.
[http://dx.doi.org/10.1016/j.ijbiomac.2017.11.048] [PMID: 29133095]

Lee, J.S.; Jung, Y.J.; Doh, M.J.; Kim, Y.M. Synthesis and properties of dextran-nalidixic acid ester as a colon-specific prodrug of nalidixic acid. Drug Dev. Ind. Pharm., 2001, 27(4), 331-336.
[http://dx.doi.org/10.1081/DDC-100103732] [PMID: 11411900]

Miao, K.H.; Guthmiller, K.B. Dextran., 2022, 70, 5-8.

Wasiak, I.; Kulikowska, A.; Janczewska, M.; Michalak, M.; Cymerman, I.A.; Nagalski, A.; Kallinger, P.; Szymanski, W.W.; Ciach, T. Dextran nanoparticle synthesis and properties. PLoS One, 2016, 11(1), e0146237.
[http://dx.doi.org/10.1371/journal.pone.0146237] [PMID: 26752182]

Bhavani, A.L.; Nisha, J. Dextran-the polysaccharide with versatile uses. Int. J. Pharm. Biol. Sci., 2010, 1(4), 569-573.

Gelin, L.E. Studies in anemia of injury. Acta Chir. Scand. Suppl., 1956, 210, 1-130.
[PMID: 13339042]

Thorsén, G. Aggregation, Sedimentation and Intravascular Sludging of Erythrocytes: Interrelation Between Suspension Stability and Colloids in Suspension Fluid: An Experimental Study; Norsdedt, 1950.

Schwartz, S.I.; Shay, H.P.; Beebe, H.; Rob, C. Effect of low molecular weight dextran on venous flow. Surgery, 1964, 55(1), 106-112.
[PMID: 14114255]

Winfrey, E.W., III; Foster, J.H. FOSTER JH. Low molecular weight dextran in small artery surgery: Antithrombogenic effect. Arch. Surg., 1964, 88(1), 78-82.
[http://dx.doi.org/10.1001/archsurg.1964.01310190080009] [PMID: 14072539]

Foster, J.H.; Killen, D.A.; Jolly, P.C.; Kirtley, J.H. Low molecular weight dextran in vascular surgery: Prevention of early thrombosis following arterial reconstruction in 85 cases. Ann. Surg., 1966, 163(5), 764-770.
[http://dx.doi.org/10.1097/00000658-196605000-00013] [PMID: 5930459]

Bergentz, S.E.; Eiken, O.; Gelin, L.E. Rheomacrodex in vascular surgery. J. Cardiovasc. Surg., 1963, 4, 388-392.
[PMID: 13970660]

Davis, J.H.; Benson, J.W.; Wolfe, M.; Nelson, B.; Abbott, W.E. The effect of capillary permeability on the maintenance of plasma volume following the administration of dextran and albumin; Surgical forum, 1955.

Ragaller, M.J.R.; Theilen, H.; Koch, T. Volume replacement in critically ill patients with acute renal failure. J. Am. Soc. Nephrol., 2001, 12(Suppl. 1), S33-S39.
[http://dx.doi.org/10.1681/ASN.V12suppl_1s33] [PMID: 11251029]

Millican, R.C.; Stohlman, E.F.; Mowry, R.W. A comparison of plasma substitutes (dextran, polyvinylpyrrolidone and oxypolygelatin) with saline therapy in treatment of experimental tourniquet and burn shock in mice. Am. J. Physiol., 1952, 170(1), 173-178.
[http://dx.doi.org/10.1152/ajplegacy.1952.170.1.173] [PMID: 12985881]

de Raucourt, E.; Mauray, S.; Chaubet, F.; Maiga-Revel, O.; Jozefowicz, M.; Fischer, A.M. Anticoagulant activity of dextran derivatives. J. Biomed. Mater. Res., 1998, 41(1), 49-57.
[http://dx.doi.org/10.1002/(SICI)1097-4636(199807)41:1<49::AID-JBM6>3.0.CO;2-Q] [PMID: 9641623]

Mauzac, M.; Jozefonvicz, J. Anticoagulant activity of dextran derivatives. Part I: Synthesis and characterization. Biomaterials, 1984, 5(5), 301-304.
[http://dx.doi.org/10.1016/0142-9612(84)90078-4] [PMID: 6207865]

Dai, F.; Du, M.; Liu, Y.; Liu, G.; Liu, Q.; Zhang, X. Folic acid-conjugated glucose and dextran coated iron oxide nanoparticles as MRI contrast agents for diagnosis and treatment response of rheumatoid arthritis. J. Mater. Chem. B Mater. Biol. Med., 2014, 2(16), 2240-2247.
[http://dx.doi.org/10.1039/C3TB21732A] [PMID: 32261712]

Chen, C.C.; Sheeran, P.S.; Wu, S.Y.; Olumolade, O.O.; Dayton, P.A.; Konofagou, E.E. Targeted drug delivery with focused ultrasound-induced blood-brain barrier opening using acoustically-activated nanodroplets. J. Control. Release, 2013, 172(3), 795-804.
[http://dx.doi.org/10.1016/j.jconrel.2013.09.025] [PMID: 24096019]

Xiao, F.; Nicholson, C.; Hrabe, J.; Hrabĕtová, S. Diffusion of flexible random-coil dextran polymers measured in anisotropic brain extra cellular space by integrative optical imaging. Biophys. J., 2008, 95(3), 1382-1392.
[http://dx.doi.org/10.1529/biophysj.107.124743] [PMID: 18456831]

Khan, M.S.; Gowda, B.H.J.; Nasir, N.; Wahab, S.; Pichika, M.R.; Sahebkar, A.; Kesharwani, P. Advancements in dextran-based nanocarriers for treatment and imaging of breast cancer. Int. J. Pharm., 2023, 643, 123276.
[http://dx.doi.org/10.1016/j.ijpharm.2023.123276] [PMID: 37516217]

Li, L.; Wang, C.; Huang, Q.; Xiao, J.; Zhang, Q.; Cheng, Y. A degradable hydrogel formed by dendrimer-encapsulated platinum nanoparticles and oxidized dextran for repeated photothermal cancer therapy. J. Mater. Chem. B Mater. Biol. Med., 2018, 6(16), 2474-2480.
[http://dx.doi.org/10.1039/C8TB00091C] [PMID: 32254464]

Chung, H.J.; Kim, H.J.; Hong, S.T. Iron-dextran as a thermosensitizer in radiofrequency hyperthermia for cancer treatment. Appl. Biol. Chem., 2019, 62(1), 24.
[http://dx.doi.org/10.1186/s13765-019-0432-6]

Prasher, P.; Sharma, M.R.; Wich, P.; Jha, N.K.; Singh, S.K.; Chellappan, D.K.; Dua, K. Can dextran-based nanoparticles mitigate inflammatory lung diseases? Future Med. Chem., 2021, 13, 2027-2031.

Nácher-Vázquez, M.; Ballesteros, N.; Canales, Á.; Rodríguez Saint-Jean, S.; Pérez-Prieto, S.I.; Prieto, A.; Aznar, R.; López, P. Dextrans produced by lactic acid bacteria exhibit antiviral and immunomodulatory activity against salmonid viruses. Carbohydr. Polym., 2015, 124, 292-301.
[http://dx.doi.org/10.1016/j.carbpol.2015.02.020] [PMID: 25839823]

Pramanik, S.; Mohanto, S.; Manne, R.; Rajendran, R.R.; Deepak, A.; Edapully, S.J.; Patil, T.; Katari, O. Nanoparticle-based drug delivery system: The magic bullet for the treatment of chronic pulmonary diseases. Mol. Pharm., 2021, 18(10), 3671-3718.
[http://dx.doi.org/10.1021/acs.molpharmaceut.1c00491] [PMID: 34491754]

Poole, P.; Sathananthan, K.; Fortescue, R. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease. Cochrane Database Syst. Rev., 2019, 5, CD001287.
[http://dx.doi.org/10.1002/14651858.CD001287.pub6]

Balde, A.; Kim, S.K.; Benjakul, S.; Nazeer, R.A. Pulmonary drug delivery applications of natural polysaccharide polymer derived nano/micro-carrier systems: A review. Int. J. Biol. Macromol., 2022, 220, 1464-1479.
[http://dx.doi.org/10.1016/j.ijbiomac.2022.09.116] [PMID: 36116588]

Feng, W.; Garrett, H.; Speert, D.P.; King, M. Improved clearability of cystic fibrosis sputum with dextran treatment in vitro. Am. J. Respir. Crit. Care Med., 1998, 157(3), 710-714.
[http://dx.doi.org/10.1164/ajrccm.157.3.9703059] [PMID: 9517580]

Prasher, P.; Sharma, M.; Singh, S.K.; Haghi, M.; MacLoughlin, R.; Chellappan, D.K.; Gupta, G.; Paudel, K.R.; Hansbro, P.M. George Oliver, B.G.; Wich, P.R.; Dua, K. Advances and applications of dextran-based nanomaterials targeting inflammatory respiratory diseases. J. Drug Deliv. Sci. Technol., 2022, 74, 103598.
[http://dx.doi.org/10.1016/j.jddst.2022.103598]

Steckel, H.; Eskandar, F.; Witthohn, K. The effect of formulation variables on the stability of nebulized aviscumine. Int. J. Pharm., 2003, 257(1-2), 181-194.
[http://dx.doi.org/10.1016/S0378-5173(03)00126-1] [PMID: 12711173]

Hulbert, W.C.; Forster, B.B.; Mehta, J.G.; Man, S.F.P.; Molday, R.S.; Walker, B.A.; Walker, D.C.; Hogg, J.C. Study of airway epithelial permeability with dextran. J. Electron Microsc. Tech., 1989, 11(2), 137-142.
[http://dx.doi.org/10.1002/jemt.1060110208] [PMID: 2468752]

Waters, R.C.; Hochhaus, G. Characterization of a dextran-budesonide prodrug for inhalation therapy. Eur. J. Pharm. Sci., 2019, 129, 58-67.
[http://dx.doi.org/10.1016/j.ejps.2018.11.038] [PMID: 30521945]

Lee, Y.; Kim, I.H.; Kim, J.; Yoon, J.H.; Shin, Y.H.; Jung, Y.; Kim, Y.M. Evaluation of dextran-flufenamic acid ester as a polymeric colon-specific prodrug of flufenamic acid, an anti-inflammatory drug, for chronotherapy. J. Drug Target., 2011, 19(5), 336-343.
[http://dx.doi.org/10.3109/1061186X.2010.499462] [PMID: 20615092]

Joshy, K.S.; George, A.; Snigdha, S.; Joseph, B.; Kalarikkal, N.; Pothen, L.A.; Thomas, S. Novel core-shell dextran hybrid nanosystem for anti-viral drug delivery. Mater. Sci. Eng. C, 2018, 93, 864-872.
[http://dx.doi.org/10.1016/j.msec.2018.08.015] [PMID: 30274122]

Kiruthika, V.; Maya, S.; Suresh, M.K.; Anil Kumar, V.; Jayakumar, R.; Biswas, R. Comparative efficacy of chloramphenicol loaded chondroitin sulfate and dextran sulfate nanoparticles to treat intracellular Salmonella infections. Colloids Surf. B Biointerfaces, 2015, 127, 33-40.
[http://dx.doi.org/10.1016/j.colsurfb.2015.01.012] [PMID: 25645750]

Kang, S.; Son, Y.; Shin, I.S.; Moon, C.; Lee, M.Y.; Lim, K.S.; Park, S.J.; Lee, C.G.; Jo, W.S.; Lee, H.J.; Kim, J.S. Effect of abdominal irradiation in mice model of inflammatory bowel disease. Radiat. Prot. Dosimetry, 2023, 199(6), 564-571.
[http://dx.doi.org/10.1093/rpd/ncad051] [PMID: 36917812]

Yazici, H.; Alpaslan, E.; Webster, T.J. The role of dextran coatings on the cytotoxicity properties of ceria nanoparticles toward bone cancer cells. J. Miner. Met. Mater. Soc., 2015, 67(4), 804-810.
[http://dx.doi.org/10.1007/s11837-015-1336-5]

Shcherbakov, A.B.; Zholobak, N.M.; Spivak, N.Y.; Ivanov, V.K. Advances and prospects of using nanocrystalline ceria in cancer theranostics. Russ. J. Inorg. Chem., 2014, 59(13), 1556-1575.
[http://dx.doi.org/10.1134/S003602361413004X]

Bernkop-Schnürch, A.; Dünnhaupt, S. Chitosan-based drug delivery systems. Eur. J. Pharm. Biopharm., 2012, 81(3), 463-469.
[http://dx.doi.org/10.1016/j.ejpb.2012.04.007] [PMID: 22561955]

Guan, X.; Zhang, W. Applications of chitosan in pulmonary drug delivery. In: Role of Novel Drug Delivery Vehicles in Nanobiomedicine; IntechOpen, 2020.
[http://dx.doi.org/10.5772/intechopen.87932]

Huang, G.; Huang, H. Application of dextran as nanoscale drug carriers. Nanomedicine, 2018, 13(24), 3149-3158.
[http://dx.doi.org/10.2217/nnm-2018-0331] [PMID: 30516091]

Veronese, F.M.; Morpurgo, M. Bioconjugation in pharmaceutical chemistry. Farmaco, 1999, 54(8), 497-516.
[http://dx.doi.org/10.1016/S0014-827X(99)00066-X] [PMID: 10510847]

Rastogi, A.; Yadav, K.; Mishra, A.; Singh, M.S.; Chaudhary, S.; Manohar, R.; Parmar, A.S. Early diagnosis of lung cancer using magnetic nanoparticles-integrated systems. Nanotechnol. Rev., 2022, 11(1), 544-574.
[http://dx.doi.org/10.1515/ntrev-2022-0032]

Sudo, E.; Boyd, W.A.; King, M. Effects of dextran sulfate on tracheal mucociliary velocity in dogs. J. Aerosol Med., 2000, 13(2), 87-96.
[http://dx.doi.org/10.1089/089426800418613] [PMID: 11010598]

Gracia, R.; Marradi, M.; Cossío, U.; Benito, A.; Pérez-San Vicente, A.; Gómez-Vallejo, V.; Grande, H.J.; Llop, J.; Loinaz, I. Synthesis and functionalization of dextran-based single-chain nanoparticles in aqueous media. J. Mater. Chem. B Mater. Biol. Med., 2017, 5(6), 1143-1147.
[http://dx.doi.org/10.1039/C6TB02773C] [PMID: 32263583]

Rosenberg, S.R.; Kalhan, R. Recent advances in the management of chronic obstructive pulmonary disease. F1000 Res., 2017, 6, 863.
[http://dx.doi.org/10.12688/f1000research.9819.1] [PMID: 28663790]

Muralidharan, P.; Hayes, D., Jr; Black, S.M.; Mansour, H.M. Microparticulate/nanoparticulate powders of a novel Nrf2 activator and an aerosol performance enhancer for pulmonary delivery targeting the lung Nrf2/Keap-1 pathway. Mol. Syst. Des. Eng., 2016, 1(1), 48-65.
[http://dx.doi.org/10.1039/C5ME00004A] [PMID: 27774309]

Kelly, R.F.; Murar, J.; Hong, Z.; Nelson, D.P.; Hong, F.; Varghese, A.; Weir, E.K. Low potassium dextran lung preservation solution reduces reactive oxygen species production. Ann. Thorac. Surg., 2003, 75(6), 1705-1710.
[http://dx.doi.org/10.1016/S0003-4975(03)00173-5] [PMID: 12822603]

Chiaramoni, N.S.; Gasparri, J.; Speroni, L.; Taira, M.C.; Alonso, S.V. Biodistribution of liposome/DNA systems after subcutaneous and intraperitoneal inoculation. J. Liposome Res., 2010, 20(3), 191-201.
[http://dx.doi.org/10.3109/08982100903244518] [PMID: 19845441]

Di Marco, M.; Shamsuddin, S.; Razak, K.A.; Aziz, A.A.; Devaux, C.; Borghi, E.; Levy, L.; Sadun, C. Overview of the main methods used to combine proteins with nanosystems: Absorption, bioconjugation, and encapsulation. Int. J. Nanomedicine, 2010, 5, 37-49.
[PMID: 20161986]

Alexescu, T.; Tarmure, S.; Negrean, V.; Cosnarovici, M.; Ruta, V.; Popovici, I.; Para, I.; Perne, M.; Orasan, O.; Todea, D. Nanoparticles in the treatment of chronic lung diseases. J. Mind Med. Sci., 2019, 6(2), 224-231.
[http://dx.doi.org/10.22543/7674.62.P224231]

Tan, Y.Y.; Yap, P.K.; Xin Lim, G.L.; Mehta, M.; Chan, Y.; Ng, S.W.; Kapoor, D.N.; Negi, P.; Anand, K.; Singh, S.K.; Jha, N.K.; Lim, L.C.; Madheswaran, T.; Satija, S.; Gupta, G.; Dua, K.; Chellappan, D.K. Perspectives and advancements in the design of nanomaterials for targeted cancer theranostics. Chem. Biol. Interact., 2020, 329, 109221.
[http://dx.doi.org/10.1016/j.cbi.2020.109221] [PMID: 32768398]

Altikatoglu, M.; Basaran, Y.; Arioz, C.; Ogan, A.; Kuzu, H. Glucose oxidase-dextran conjugates with enhanced stabilities against temperature and pH. Appl. Biochem. Biotechnol., 2010, 160(8), 2187-2197.
[http://dx.doi.org/10.1007/s12010-009-8812-8] [PMID: 20054664]

Zhong, G.; Zhang, S.; Li, Y.; Liu, X.; Gao, R.; Miao, Q.; Zhen, Y. A tandem scFv-based fusion protein and its enediyne-energized analogue show intensified therapeutic efficacy against lung carcinoma xenograft in athymic mice. Cancer Lett., 2010, 295(1), 124-133.
[http://dx.doi.org/10.1016/j.canlet.2010.02.020] [PMID: 20303650]

Sood, A.; Gupta, A.; Agrawal, G. Recent advances in polysaccharides based biomaterials for drug delivery and tissue engineering applications. Carbohydr. Polym. Technol. Appl., 2021, 2(March), 100067.
[http://dx.doi.org/10.1016/j.carpta.2021.100067]

Byrne, A.L.; Marais, B.J.; Mitnick, C.D.; Lecca, L.; Marks, G.B. Tuberculosis and chronic respiratory disease: A systematic review. Int. J. Infect. Dis., 2015, 32, 138-146.
[http://dx.doi.org/10.1016/j.ijid.2014.12.016] [PMID: 25809770]

Kushwaha, S. Targeted macrophages delivery of antitubercular agent through solid lipid nanoparticles. Lett. Appl. NanoBioSci., 2022, 12(1), 3.
[http://dx.doi.org/10.33263/LIANBS121.003]

Byron, P.R.; Patton, J.S. Drug delivery via the respiratory tract. J. Aerosol Med., 1994, 7(1), 49-75.
[http://dx.doi.org/10.1089/jam.1994.7.49] [PMID: 10147058]

Theng, B.K.G. Polysaccharides. In: Developments in Clay Science; , 2012; 4, pp. 351-390.

Smola, M.; Vandamme, T.; Sokolowski, A. Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases. Int. J. Nanomedicine, 2008, 3(1), 1-19.
[PMID: 18488412]

Kaewprapan, K.; Inprakhon, P.; Marie, E.; Durand, A. Enzymatically degradable nanoparticles of dextran esters as potential drug delivery systems. Carbohydr. Polym., 2012, 88(3), 875-881.
[http://dx.doi.org/10.1016/j.carbpol.2012.01.030]

Tang, Y.; Li, Y.; Xu, R.; Li, S.; Hu, H.; Xiao, C.; Wu, H.; Zhu, L.; Ming, J.; Chu, Z.; Xu, H.; Yang, X.; Li, Z. Self-assembly of folic acid dextran conjugates for cancer chemotherapy. Nanoscale, 2018, 10(36), 17265-17274.
[http://dx.doi.org/10.1039/C8NR04657C] [PMID: 30191943]

Tarvirdipour, S.; Vasheghani-Farahani, E.; Soleimani, M.; Bardania, H. Functionalized magnetic dextran-spermine nanocarriers for targeted delivery of doxorubicin to breast cancer cells. Int. J. Pharm., 2016, 501(1-2), 331-341.
[http://dx.doi.org/10.1016/j.ijpharm.2016.02.012] [PMID: 26875475]

Ying, F. Doxorubicin-loaded dextran-based nano-carriers for highly efficient inhibition of lymphoma cell growth and synchronous reduction of cardiac toxicity. Int. J. Nanomedicine, 2018, 13, 5673-5683.

Lv, W.; Xu, J.; Wang, X.; Li, X.; Xu, Q.; Xin, H. Bioengineered boronic ester modified dextran polymer nanoparticles as reactive oxygen species responsive nanocarrier for ischemic stroke treatment. ACS Nano, 2018, 12(6), 5417-5426.
[http://dx.doi.org/10.1021/acsnano.8b00477] [PMID: 29869497]

Alhaique, F.; Casadei, M.A.; Cencetti, C.; Coviello, T.; Di Meo, C.; Matricardi, P.; Montanari, E.; Pacelli, S.; Paolicelli, P. From macro to nano polysaccharide hydrogels: An opportunity for the delivery of drugs. J. Drug Deliv. Sci. Technol., 2016, 32, 88-99.
[http://dx.doi.org/10.1016/j.jddst.2015.09.018]

Morsi, N.; Ibrahim, M.; Refai, H.; El Sorogy, H. Nanoemulsion-based electrolyte triggered in situ gel for ocular delivery of acetazolamide. Eur. J. Pharm. Sci., 2017, 104, 302-314.
[http://dx.doi.org/10.1016/j.ejps.2017.04.013] [PMID: 28433750]

Zhou, Y.; Wang, S.; Ying, X.; Wang, Y.; Geng, P.; Deng, A.; Yu, Z. Doxorubicin-loaded redox-responsive micelles based on dextran and indomethacin for resistant breast cancer. Int. J. Nanomedicine, 2017, 12, 6153-6168.
[http://dx.doi.org/10.2147/IJN.S141229] [PMID: 28883726]

Fan, Y.; Yi, J.; Zhang, Y.; Yokoyama, W. Fabrication of curcumin-loaded bovine serum albumin (BSA)-dextran nanoparticles and the cellular antioxidant activity. Food Chem., 2018, 239, 1210-1218.
[http://dx.doi.org/10.1016/j.foodchem.2017.07.075] [PMID: 28873542]

Jafari, M.; Kaffashi, B. Synthesis and characterization of a novel solvent-free dextran-HEMA-PNIPAM thermosensitive nanogel. J. Macromol. Sci. Part A Pure Appl. Chem., 2016, 53(2), 68-74.
[http://dx.doi.org/10.1080/10601325.2016.1120173]

Nakajima, N.; Sugai, H.; Tsutsumi, S.; Hyon, S.H. Self-degradable bioadhesive. Polym Prepr Japan., 2006, 55(1), 1998.

Liu, J.; Qi, C.; Tao, K.; Zhang, J.; Zhang, J.; Xu, L.; Jiang, X.; Zhang, Y.; Huang, L.; Li, Q.; Xie, H.; Gao, J.; Shuai, X.; Wang, G.; Wang, Z.; Wang, L. Sericin/Dextran injectable hydrogel as an optically trackable drug delivery system for malignant melanoma treatment. ACS Appl. Mater. Interfaces, 2016, 8(10), 6411-6422.
[http://dx.doi.org/10.1021/acsami.6b00959] [PMID: 26900631]

Chen, X.; Chen, L.; Yao, X.; Zhang, Z.; He, C.; Zhang, J.; Chen, X. Dual responsive supramolecular nanogels for intracellular drug delivery. Chem. Commun., 2014, 50(29), 3789-3791.
[http://dx.doi.org/10.1039/c4cc00016a] [PMID: 24519486]

Ma, S.; Zhou, J.; Wali, A.R.M.; He, Y.; Xu, X.; Tang, J.Z.; Gu, Z. Self-assembly of pH-sensitive fluorinated peptide dendron functionalized dextran nanoparticles for on-demand intracellular drug delivery. J. Mater. Sci. Mater. Med., 2015, 26(8), 219.
[http://dx.doi.org/10.1007/s10856-015-5550-z] [PMID: 26238777]

Fu, Y.; Li, Y.; Li, G.; Yang, L.; Yuan, Q.; Tao, L.; Wang, X. Adaptive chitosan hollow microspheres as efficient drug carrier. Biomacromolecules, 2017, 18(7), 2195-2204.
[http://dx.doi.org/10.1021/acs.biomac.7b00592] [PMID: 28558194]

Hou, X.; Liu, Y. Preparation and drug controlled release of porous octyl-dextran microspheres. J. Biomater. Sci. Polym. Ed., 2015, 26(15), 1051-1066.
[http://dx.doi.org/10.1080/09205063.2015.1077917] [PMID: 26230155]

Zhang, R.; Jia, X.; Pei, M.; Liu, P. Facile preparation of pH/reduction dual-responsive prodrug microspheres with high drug content for tumor intracellular triggered release of DOX. React. Funct. Polym., 2017, 116(116), 24-30.
[http://dx.doi.org/10.1016/j.reactfunctpolym.2017.05.002]

Pekarek, K.J.; Jacob, J.S.; Mathiowitz, E. Double-walled polymer microspheres for controlled drug release. Nature, 1994, 367(6460), 258-260.
[http://dx.doi.org/10.1038/367258a0] [PMID: 8121490]

Broaders, K.E.; Grandhe, S.; Fréchet, J.M.J. A biocompatible oxidation-triggered carrier polymer with potential in therapeutics. J. Am. Chem. Soc., 2011, 133(4), 756-758.
[http://dx.doi.org/10.1021/ja110468v] [PMID: 21171594]

Kauffman, K.J.; Kanthamneni, N.; Meenach, S.A.; Pierson, B.C.; Bachelder, E.M.; Ainslie, K.M. Optimization of rapamycin-loaded acetalated dextran microparticles for immunosuppression. Int. J. Pharm., 2012, 422(1-2), 356-363.
[http://dx.doi.org/10.1016/j.ijpharm.2011.10.034] [PMID: 22037446]

Chen, N.; Gallovic, M.D.; Tiet, P.; Ting, J.P.Y.; Ainslie, K.M.; Bachelder, E.M. Investigation of tunable acetalated dextran microparticle platform to optimize M2e-based influenza vaccine efficacy. J. Control. Release, 2018, 289, 114-124.
[http://dx.doi.org/10.1016/j.jconrel.2018.09.020] [PMID: 30261204]

Graf, M.; Ziegler, C.E.; Gregoritza, M.; Goepferich, A.M. Hydrogel microspheres evading alveolar macrophages for sustained pulmonary protein delivery. Int. J. Pharm., 2019, 566, 652-661.
[http://dx.doi.org/10.1016/j.ijpharm.2019.06.019] [PMID: 31181308]

Kwon, G.S.; Okano, T. Polymeric micelles as new drug carriers. Adv. Drug Deliv. Rev., 1996, 21(2), 107-116.
[http://dx.doi.org/10.1016/S0169-409X(96)00401-2]

Kataoka, K.; Harada, A.; Nagasaki, Y. Block copolymer micelles for drug delivery: Design, characterization and biological significance. Adv. Drug Deliv. Rev., 2012, 64(Suppl.), 37-48.
[http://dx.doi.org/10.1016/j.addr.2012.09.013] [PMID: 11251249]

Kwon, G.S.; Furgeson, D.Y. Biodegradable polymers for drug delivery systems. In: Biomedical Polymers; Woodhead Publishing Limited, 2007.
[http://dx.doi.org/10.1533/9781845693640.83]

Zhang, X.; Burt, H.M.; Mangold, G.; Dexter, D.; Hoff, D.V.; Mayer, L.; Hunter, W.L. Anti-tumor efficacy and biodistribution of intravenous polymeric micellar paclitaxel. Anticancer Drugs, 1997, 8(7), 696-701.
[http://dx.doi.org/10.1097/00001813-199708000-00008] [PMID: 9311446]

Pilcer, G.; Amighi, K. Formulation strategy and use of excipients in pulmonary drug delivery. Int. J. Pharm., 2010, 392(1-2), 1-19.
[http://dx.doi.org/10.1016/j.ijpharm.2010.03.017] [PMID: 20223286]

Du, Y.Z.; Weng, Q.; Yuan, H.; Hu, F.Q. Synthesis and antitumor activity of stearate-g-dextran micelles for intracellular doxorubicin delivery. ACS Nano, 2010, 4(11), 6894-6902.
[http://dx.doi.org/10.1021/nn100927t] [PMID: 20939508]

Nikolaizik, W.H.; Vietzke, D.; Ratjen, F. A pilot study to compare tobramycin 80 mg injectable preparation with 300 mg solution for inhalation in cystic fibrosis patients. Can. Respir. J., 2008, 15(5), 259-262.
[http://dx.doi.org/10.1155/2008/202464] [PMID: 18716688]

Kuehl, P.J.; Cherrington, A.; Dobry, D.E.; Edgerton, D.; Friesen, D.T.; Hobbs, C.; Leach, C.L.; Murri, B.; Neal, D.; Lyon, D.K.; Vodak, D.T.; Reed, M.D. Biologic comparison of inhaled insulin formulations: Exubera™ and novel spray-dried engineered particles of dextran-10. AAPS PharmSciTech, 2014, 15(6), 1545-1550.
[http://dx.doi.org/10.1208/s12249-014-0181-0] [PMID: 25106135]

Rosière, R.; Van Woensel, M.; Langer, I.; Mathieu, V.; Amighi, K.; Wauthoz, N. Nanomicelle-based dry powders for inhalation for targeted delivery to lung cancer cells : In vitro evaluation and in vivo local pulmonary tolerance on healthy mice. Europ. Conf. Pharmaceut., 2015.

Kadota, K.; Yanagawa, Y.; Tachikawa, T.; Deki, Y.; Uchiyama, H.; Shirakawa, Y.; Tozuka, Y. Development of porous particles using dextran as an excipient for enhanced deep lung delivery of rifampicin. Int. J. Pharm., 2019, 555, 280-290.
[http://dx.doi.org/10.1016/j.ijpharm.2018.11.055] [PMID: 30471373]

Figueiredo-Junior, A.T.; Valença, S.S.; Finotelli, P.V.; Anjos, F.F.; de Brito-Gitirana, L.; Takiya, C.M.; Lanzetti, M. Treatment with bixin-loaded polymeric nanoparticles prevents cigarette smoke-induced acute lung inflammation and oxidative stress in mice. Antioxidants, 2022, 11(7), 1293.
[http://dx.doi.org/10.3390/antiox11071293] [PMID: 35883784]

Nainwal, N.; Sharma, Y.; Jakhmola, V. Dry powder inhalers of antitubercular drugs. Tuberculosis, 2022, 135, 102228.
[http://dx.doi.org/10.1016/j.tube.2022.102228] [PMID: 35779497]

Mary, J. The effects of anoxia on the newborn and adult rat lung. J. Geotech. Geoenvironmental. Eng. ASCE., 1964, 137(84), 641-645.

El-Sherbiny, I.M.; Elbaz, N.M.; Sedki, M.; Elgammal, A.; Yacoub, M.H. Magnetic nanoparticles-based drug and gene delivery systems for the treatment of pulmonary diseases. Nanomedicine, 2017, 12(4), 387-402.
[http://dx.doi.org/10.2217/nnm-2016-0341] [PMID: 28078950]

Blanco-Cabra, N.; Movellan, J.; Marradi, M.; Gracia, R.; Salvador, C.; Dupin, D.; Loinaz, I.; Torrents, E. Neutralization of ionic interactions by dextran-based single-chain nanoparticles improves tobramycin diffusion into a mature biofilm. NPJ Biofilms Microbiomes, 2022, 8(1)

Vadakkan, M.V.; Binil Raj, S.S.; Kartha, C.C.; Vinod Kumar, G.S. Cationic, amphiphilic dextran nanomicellar clusters as an excipient for dry powder inhaler formulation. Acta Biomater., 2015, 23, 172-188.
[http://dx.doi.org/10.1016/j.actbio.2015.05.019] [PMID: 26013041]

Shkurupiy, V.A.; Chernova, T.G.; Nadeev, A.P. Granulomatous inflammation in the lungs of mice with systemic candidiasis receiving a composition of amphotericin B and dialdehyde dextran. Bull. Exp. Biol. Med., 2008, 146(6), 829-831.
[http://dx.doi.org/10.1007/s10517-009-0410-9] [PMID: 19513397]

Shkurupiy, V.A.; Kozyaev, M.A.; Potapova, O.V. Morphological study of the efficiency of isoniazid and dialdehyde dextran composition in the treatment of mice with BCG granulomatosis. Bull. Exp. Biol. Med., 2008, 146(6), 853-856.
[http://dx.doi.org/10.1007/s10517-009-0401-x] [PMID: 19513404]

Almasi, T.; Jabbari, K.; Gholipour, N.; Mokhtari Kheirabadi, A.; Beiki, D.; Shahrokhi, P.; Akhlaghi, M. Synthesis, characterization, and in vitro and in vivo68Ga radiolabeling of thiosemicarbazone Schiff base derived from dialdehyde dextran as a promising blood pool imaging agent. Int. J. Biol. Macromol., 2019, 125, 915-921.
[http://dx.doi.org/10.1016/j.ijbiomac.2018.12.133] [PMID: 30572040]

Jin, F.; Cheng, Y.; Toda, K. Distribution model for the intact urokinase and urokinases modified by soluble macromolecules in rat and mouse bodies. Radioisotopes, 1988, 37(8), 441-447.
[http://dx.doi.org/10.3769/radioisotopes.37.8_441] [PMID: 2464842]

Li, B.; Liu, X.; Li, L.; Zhang, S.; Li, Y.; Li, D.; Zhen, Y. A tumor-targeting dextran-apoprotein conjugate integrated with enediyne chromophore shows highly potent antitumor efficacy. Polym. Chem., 2014, 5(19), 5680-5688.
[http://dx.doi.org/10.1039/C4PY00532E]

Richmond, H.G. Induction of sarcoma in the rat by iron-dextran complex. BMJ, 1959, 1(5127), 947-940.
[http://dx.doi.org/10.1136/bmj.1.5127.947] [PMID: 13638595]

Potapova, O.V.; Cherdantseva, L.A.; Kovner, A.V.; Sharkova, T.V.; Troitskii, A.V.; Shestopalov, A.M.; Shkurupy, V.A. Preventive effects of oxidized dextran on functional activity of pulmonary macrophages in mice infected with influenza a virus. Bull. Exp. Biol. Med., 2018, 165(1), 57-60.
[http://dx.doi.org/10.1007/s10517-018-4098-6] [PMID: 29796811]

Chis, A.A.; Arseniu, A.M.; Morgovan, C.; Dobrea, C.M.; Frum, A.; Juncan, A.M.; Butuca, A.; Ghibu, S.; Gligor, F.G.; Rus, L.L. Biopolymeric prodrug systems as potential antineoplastic therapy. Pharmaceutics, 2022, 14(9), 1773.
[http://dx.doi.org/10.3390/pharmaceutics14091773] [PMID: 36145522]